Authorization of Issue of Series B Notes Sample Clauses

Authorization of Issue of Series B Notes. The Company will authorize the issue of its senior promissory notes (the “Series B Notes”) in the aggregate principal amount of $100,000,000, to be dated the date of issue thereof, to mature May 4, 2027, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 3.10% per annum, but at the Default Rate if an Event of Default has occurred and is continuing and at the Default Rate on any overdue Make Whole Amount and interest, and to be substantially in the form of Exhibit A-1 attached hereto. The terms “Series B Note” and “Series B Notes” as used herein shall include each such senior promissory note delivered pursuant to any provision of this Agreement and each such senior promissory note delivered in substitution or exchange for any other Series B Note pursuant to any such provision. Capitalized terms used herein have the meanings specified in paragraph 10.
AutoNDA by SimpleDocs
Authorization of Issue of Series B Notes. The Company has authorized the issue of its senior secured promissory notes (the "Series B Notes") in the aggregate principal amount of $105,000,000, to be dated the date of issue thereof, to mature May 19, 2020, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 4.79% per annum and on overdue payments at the rate per annum set forth therein, and to be substantially in the form of Exhibit A-2 ----------- attached hereto. The term "Series B Notes" as used herein shall include each such Series B Note delivered pursuant to any provision of this Agreement and each such Series B Note delivered in substitution or exchange for any other Series B Note pursuant to any such provision and the term "Notes" as used herein shall include each Series A Note and each Series B Note.
Authorization of Issue of Series B Notes. The Company will authorize the issue of the Series B Notes in the aggregate principal amount of $25,000,000, to be dated the date of issue thereof, to mature April 30, 2014, to bear interest (computed on the basis of a 360 day year -- 30 day month) on the unpaid balance thereof from the date thereof until the principal thereof shall have become due at the rate of 6.70% per annum, and on overdue principal, Yield- Maintenance Amount and interest at the rate and at the time specified therein, and to be substantially in the form of Exhibit A-2 attached hereto.
Authorization of Issue of Series B Notes. The Company will authorize the issue of its senior promissory notes (the "Series B Notes") in the aggregate principal amount of $50,000,000, to be dated the date of issue thereof, to mature April 15, 2017, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 7.72% per annum and on overdue principal, Yield-Maintenance Amount and interest at the rate specified therein, and to be substantially in the form of Exhibit A-1 attached hereto. The term "Series B Notes" as used herein shall include each Series B Note delivered pursuant to any provision of this Agreement and each Series B Note delivered in substitution or exchange for any such Note pursuant to any such provision.
Authorization of Issue of Series B Notes. The Company will authorize the issue and sale of US$75,000,000 aggregate principal amount of its 5.35% Series B Guaranteed Senior Notes due June 2, 2023 (as amended, restated, supplemented or otherwise modified from time to time, the “Series B Notes”, such term to include any such notes issued in substitution, replacement or exchange therefore pursuant to paragraph 13, and the Series B Notes and the Series A Notes, collectively, the “Notes”). The Series B Notes shall be substantially in the form set out in Schedule 1-B.
Authorization of Issue of Series B Notes. The Company will authorize the issue of its senior promissory notes (the “Series B Notes”) in the aggregate principal amount of $75,000,000, to be dated the date of issue thereof, to mature March 11, 2023, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 5.01% per annum (provided that, during any period when an Event of Default shall be in existence, at the election of the Required Holder(s) of the Series B Notes the outstanding principal balance of the Series B Notes shall bear interest from and after the date of such Event of Default and until the date such Event of Default ceases to be in existence at the rate per annum from time to time equal to the Default Rate and on overdue payments (other than overdue payments of principal if the Required Holders have elected to require the entire outstanding principal amount of the Series B Notes to bear interest at the Default Rate) at the rate per annum from time to time equal to the Default Rate, and to be substantially in the form of Exhibit A-2 attached hereto.
Authorization of Issue of Series B Notes. The Co-Makers will authorize the issue of their joint and several senior promissory notes, Series B, in the aggregate principal amount of $50,000,000: (i) to be dated the date of issue thereof ; (ii) to mature January 31, 2006; (iii) to bear interest (A) on the unpaid balance thereof through July 31, 1999, at the rate of 6.76% per annum; from August 1, 1999 through October 31, 1999, at the rate of 7.51%; from November 1, 1999 through January 31, 2000, at the rate of 8.26%; from February 1, 2000 through April 30, 2000, at the rate of 8.76%; and from May 1, 2000 until the principal thereof shall have become due and payable at the rate of 9.26% and (B) on overdue payments at the rate specified therein, and to be substantially in the form of Exhibit B attached hereto. The term "Series B Notes" as used --------- herein shall include-each such senior promissory note, Series B, delivered pursuant to any provision of this Agreement and each such senior promissory note delivered in substitution or exchange for any other Series B Note pursuant to any such provision.
AutoNDA by SimpleDocs
Authorization of Issue of Series B Notes. The Co-Makers will authorize the issue of their joint and several senior promissory notes, Series B, in the aggregate principal amount of $50,000,000: (i) to be dated the date of issue thereof ; (ii)to mature January 31, 2006; (iii) to bear interest (A) on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 6.76% per annum, provided, however, that if a Credit Agreement Termination has not occurred on or prior to August 1, 1999, such unpaid balance shall bear interest commencing August 1, 1999, until the principal thereof shall have become due and payable, at the rate of 10.76% per annum and (B) on overdue payments at the rate specified therein, and to be substantially in the form of Exhibit B attached hereto. The term "Series B Notes" as used herein shall include each such senior promissory note, Series B, delivered pursuant to any provision of this Agreement and each such senior promissory note delivered in substitution or exchange for any other Series B Note pursuant to any such provision.
Authorization of Issue of Series B Notes. The Company will authorize the issue of its senior promissory notes (the “Series B Notes”) in the aggregate principal amount of $10,000,000, to be dated the date of issue thereof, to mature May 15, 2030, to bear interest on the unpaid balance thereof from the date thereof until the principal thereof shall have become due and payable at the rate of 3.95% per annum (provided that, during any period when an Event of Default shall be in existence, at the election of the Required Holder(s) of the Series B Notes the outstanding principal balance of the Series B Notes shall bear interest from and after the date of such Event of

Related to Authorization of Issue of Series B Notes

  • Authorization of Issuers Each Grantor hereby expressly and irrevocably authorizes and instructs, without any further instructions from such Grantor, each issuer of any Pledged Collateral pledged hereunder by such Grantor to (i) comply with any instruction received by it from Agent in writing that states that an Event of Default is continuing and is otherwise in accordance with the terms of this Agreement and each Grantor agrees that such issuer shall be fully protected from Liabilities to such Grantor in so complying and (ii) unless otherwise expressly permitted hereby or the Credit Agreement, pay any dividend or make any other payment with respect to the Pledged Collateral directly to Agent.

  • Authorization of Indenture The Indenture has been duly authorized by the Company and, on the Closing Date, will have been duly executed and delivered by the Company, and assuming due authorization, execution and delivery of the Indenture by the Indenture Trustee, the Indenture will constitute a valid, legal and binding agreement of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by the Enforceability Exceptions.

  • Authorization of Notes The Company will authorize the issue and sale of $53,500,000 aggregate principal amount of its 7.25% Senior Notes due December 30, 2029 (the “Notes”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

  • Due Authorization and Issuance All of the Pledged Securities existing on the date hereof have been, and to the extent any Pledged Securities are hereafter issued, such Pledged Securities will be, upon such issuance, duly authorized, validly issued and fully paid and non-assessable to the extent applicable. There is no amount or other obligation owing by any Pledgor to any issuer of the Pledged Securities in exchange for or in connection with the issuance of the Pledged Securities or any Pledgor’s status as a partner or a member of any issuer of the Pledged Securities.

  • Due Authorization and Valid Issuance The Company has all requisite power and authority to execute, deliver and perform its obligations under the Agreements, and the Agreements have been duly authorized and validly executed and delivered by the Company and constitute legal, valid and binding agreements of the Company enforceable against the Company in accordance with their terms, except as rights to indemnity and contribution may be limited by state or federal securities laws or the public policy underlying such laws, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' and contracting parties' rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). The Shares being purchased by the Investor hereunder will, upon issuance and payment therefor pursuant to the terms hereof, be duly authorized, validly issued, fully-paid and nonassessable.

  • Qualification of Indenture The Company shall qualify this Indenture under the TIA in accordance with the terms and conditions of the Registration Rights Agreement and shall pay all reasonable costs and expenses (including attorneys' fees and expenses for the Company, the Trustee and the Holders) incurred in connection therewith, including, but not limited to, costs and expenses of qualification of this Indenture and the Securities and printing this Indenture and the Securities. The Trustee shall be entitled to receive from the Company any such Officers' Certificates, Opinions of Counsel or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the TIA.

  • Ratification of Indenture The Indenture, as supplemented by this Supplemental Indenture, is in all respects ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided.

  • Registration of Investments Domestic investments held by the Custodian (other than bearer securities) shall be registered in the name of the Fund or in the name of any nominee of the Fund or of any nominee of the Custodian which nominee shall be assigned exclusively to the Fund, unless the Fund has authorized in writing the appointment of a nominee to be used in common with other registered investment companies having the same investment adviser as the Fund, or in the name or nominee name of any agent appointed pursuant to Section 2.8 or in the name or nominee name of any sub- custodian appointed pursuant to Section 1. All securities accepted by the Custodian on behalf of the Fund under the terms of this Agreement shall be in good deliverable form. If, however, the Fund directs the Custodian to maintain securities in “street name”, the Custodian shall utilize its best efforts only to timely collect income due the Fund on such securities and to notify the Fund of relevant corporate actions including, without limitation, pendency of calls, maturities, tender or exchange offers.

  • Authorization of the Notes The Notes to be purchased by the Underwriters from the Company are in the form contemplated by the Indenture, have been duly authorized for issuance and sale pursuant to this Agreement and the Indenture and, at the Closing Date, will have been duly executed by the Company and, when authenticated in the manner provided for in the Indenture and delivered against payment of the purchase price therefor, will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable principles, and will be entitled to the benefits of the Indenture.

  • Due Authorization, etc The execution, delivery and performance by the Borrower of this Agreement are within the Borrower’s corporate powers, have been duly authorized by all necessary corporate action, and do not contravene (i) the Borrower’s certificate of incorporation or bylaws or (ii) law or any material contractual restriction binding on or affecting the Borrower.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!